9-membered fused ring derivative

The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I), R

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nishiura, Yuji, Kurahashi, Kana, Iwatsu, Masafumi, Miyazaki, Keisuke, Katou, Manabu, Wada, Toshihiro, Ohyabu, Naoki, Sasaki, Yoshikazu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Nishiura, Yuji
Kurahashi, Kana
Iwatsu, Masafumi
Miyazaki, Keisuke
Katou, Manabu
Wada, Toshihiro
Ohyabu, Naoki
Sasaki, Yoshikazu
description The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I), R
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016240715BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016240715BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016240715BB23</originalsourceid><addsrcrecordid>eNrjZFCw1M1NzU1KLUpNUUgrLQaSRZl56QopqUWZZYklmWWpPAysaYk5xam8UJqbQcXNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDQzMjEwNzQ1MnJyJhIZQASsyZa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>9-membered fused ring derivative</title><source>esp@cenet</source><creator>Nishiura, Yuji ; Kurahashi, Kana ; Iwatsu, Masafumi ; Miyazaki, Keisuke ; Katou, Manabu ; Wada, Toshihiro ; Ohyabu, Naoki ; Sasaki, Yoshikazu</creator><creatorcontrib>Nishiura, Yuji ; Kurahashi, Kana ; Iwatsu, Masafumi ; Miyazaki, Keisuke ; Katou, Manabu ; Wada, Toshihiro ; Ohyabu, Naoki ; Sasaki, Yoshikazu</creatorcontrib><description>The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I), R</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201008&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016240715B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201008&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016240715B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Nishiura, Yuji</creatorcontrib><creatorcontrib>Kurahashi, Kana</creatorcontrib><creatorcontrib>Iwatsu, Masafumi</creatorcontrib><creatorcontrib>Miyazaki, Keisuke</creatorcontrib><creatorcontrib>Katou, Manabu</creatorcontrib><creatorcontrib>Wada, Toshihiro</creatorcontrib><creatorcontrib>Ohyabu, Naoki</creatorcontrib><creatorcontrib>Sasaki, Yoshikazu</creatorcontrib><title>9-membered fused ring derivative</title><description>The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I), R</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFCw1M1NzU1KLUpNUUgrLQaSRZl56QopqUWZZYklmWWpPAysaYk5xam8UJqbQcXNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDQzMjEwNzQ1MnJyJhIZQASsyZa</recordid><startdate>20201008</startdate><enddate>20201008</enddate><creator>Nishiura, Yuji</creator><creator>Kurahashi, Kana</creator><creator>Iwatsu, Masafumi</creator><creator>Miyazaki, Keisuke</creator><creator>Katou, Manabu</creator><creator>Wada, Toshihiro</creator><creator>Ohyabu, Naoki</creator><creator>Sasaki, Yoshikazu</creator><scope>EVB</scope></search><sort><creationdate>20201008</creationdate><title>9-membered fused ring derivative</title><author>Nishiura, Yuji ; Kurahashi, Kana ; Iwatsu, Masafumi ; Miyazaki, Keisuke ; Katou, Manabu ; Wada, Toshihiro ; Ohyabu, Naoki ; Sasaki, Yoshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016240715BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Nishiura, Yuji</creatorcontrib><creatorcontrib>Kurahashi, Kana</creatorcontrib><creatorcontrib>Iwatsu, Masafumi</creatorcontrib><creatorcontrib>Miyazaki, Keisuke</creatorcontrib><creatorcontrib>Katou, Manabu</creatorcontrib><creatorcontrib>Wada, Toshihiro</creatorcontrib><creatorcontrib>Ohyabu, Naoki</creatorcontrib><creatorcontrib>Sasaki, Yoshikazu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Nishiura, Yuji</au><au>Kurahashi, Kana</au><au>Iwatsu, Masafumi</au><au>Miyazaki, Keisuke</au><au>Katou, Manabu</au><au>Wada, Toshihiro</au><au>Ohyabu, Naoki</au><au>Sasaki, Yoshikazu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>9-membered fused ring derivative</title><date>2020-10-08</date><risdate>2020</risdate><abstract>The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I), R</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2016240715BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 9-membered fused ring derivative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Nishiura,%20Yuji&rft.date=2020-10-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016240715BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true